Julia CadrinTourigny
@JuliaCTourigny
Followers
184
Following
2K
Media
2
Statuses
97
Joined September 2014
0
9
28
Gene-specific insights are transforming ARVC diagnosis, risk prediction & therapy. Precision medicine is here: https://t.co/my3AMMQOTx
0
2
3
📚 Explore this case series on systemic sclerosis (#SSc) presenting as arrhythmogenic cardiomyopathy (#ACM), highlighting key insights to differentiate SSc-related cardiomyopathy from primary ACM ⬇️ https://t.co/9FhLPV7qZR
#Cardiology #Arrhythmia #Cardiomyopathy #Myocarditis
0
3
4
Very proud to attend #HRS2025 to present our multicentric study assesing the role of depolarization ECG parameters to predict arrhythmic events in ARVC patients ⚡ @ICMtl thanks to my mentor @JuliaCTourigny !
1
3
19
Sunny skies and cutting-edge science await as #HRS2025 kicks off this week in San Diego! Check out the exciting line-up of talks and posters by HiRO investigators as they dive into the latest in #cardiogenetics 🧬🫀
0
1
1
🔴 Clinical Effect of Genetic Testing in Inherited Cardiovascular Diseases: A 14-Year Retrospective Study @JACCJournals #CardioEd #Cardiology #Genetics
1
33
95
Don’t use the #ARVC #risk #calculators in relatives without 2010 TFC fulfillment as it leads to unnecessary and potentially harmful #ICD implantations @SCYap77 @JuliaCTourigny @jpvantintelen @BabkenAsatryan @gasperettimd @ERNGUARDHeart #AHAJournals #Epeeps
ahajournals.org
0
8
18
MARQUEZ VOS CALENDRIERS! 📅 Joignez-vous à nous pour la 3e Conférence annuelle sur les maladies cardiaques rares. Des spécialistes de différentes disciplines s’exprimeront sur divers sujets liés aux maladies cardiaques rares. 🔗 S'inscrire : https://t.co/EVU9YuEqgp
0
2
3
Save the date! March 20-22, 2025 - the unmissable dates for passionates of hereditary CV diseases. An online course, English language only, with a faculty including many of the most important experts in the fields. Free inscription. Follow https://t.co/aAYhKBMXAN for details!
2
10
19
Congratulations to @RivardLena on the @AHAScience presentation of the BRAIN-AF study results. Major observation is that cognitive decline occurs in many « low risk » AF patients. Unfortunately, Rivaroxaban 15 mg daily did not impact this risk in this double-dummy RCT.
3
16
54
An #AHA24 Pre-LBCT session 2 selfie with two PIs - Léna Rivard from @ICMtl presenting the results from BRAIN-AF, and - John Sapp from @DalhousieU presenting the results from VANISH-2
0
3
35
Another day working towards gene-specific criteria for #ARVC #ACM arrythmogenic cardiomyopathy in Zurich. This morning PKP2 DSG2 DSC2 DSP PLN and TMEM43 @CardioZurich
1
3
11
Exciting symposium on arrhythmogenic cardiomyopathy (#ACM #ARVC). Working towards gene-specific criteria with many of my great colleagues on day 1: @JuliaCTourigny @HughCalkinsMD @ASaguner @Cristinabasso64 @MarioDelmar3 @COpbergen @KristinaHaugaa @jpkaski
1
9
38
FRESH OFF THE PRESS - New study in @escardio @ESC_Journals Prediction of incident atrial fibrillation using deep learning, clinical models and polygenic scores shows #AI can predict new-onset atrial fibrillation from ECGs with high accuracy, outperforming clinical and genetic
2
19
57
Another development of the #AI lab of @RobertAvramMD with rapid clinical implementation!
Excited to share our abstract on real-time ejection fraction prediction using angiograms at #ESCCongress2024 🎉 Join us at Station 8 - Research Gateway @ 2PM to learn about CathEF, our video-based AI for LVEF assessment. #CardioTwitter #AIinHealthcare @escardio @therlaup @ICMtl
0
1
7
👆🏼my editorial on the new DSP risk score https://t.co/LgDBhsscFt by @RTCarrick @gasperettimd and colleagues
academic.oup.com
AbstractBackground and Aims. Pathogenic desmoplakin (DSP) gene variants are associated with the development of a distinct form of arrhythmogenic cardiomyop
0
3
14
Proud to see this world wide effort for #DSP finally out! Kudos to my DSP-erados partner @RTCarrick for bringing this paper home and thanks to the many collaborators @ProtonotariosA @HughCalkinsMD @LaredoMikael @AdamHelmsMD @vnparikh @jpvantintelen @teRieleA @JuliaCTourigny
Arrhythmogenic Cardiomyopathy Risk 🧬 #Genetics #HeartHealth #Research New study introduces a tool to assess arrhythmic risk in DSP gene variant carriers @ehj_ed
3
6
26
We are excited about our upcoming HiRO symposium focusing on optimal approaches to care and emerging targeted and gene-based therapeutics for inherited arrhythmia and cardiomyopathy patients!
Don't forget to register for virtual attendance at the 8th Annual HiRO Symposium this June 7th-8th! We're thrilled to host international keynote speakers Dr. Dominic Abrams and Dr. Cindy James Don't miss industry panels with @CanadianSADS to hear the latest on novel therapies
0
5
11
Le @FRQS1 est fier d'appuyer les recherches du cardiologue @rafik_tadros @ICMtl @med_umontreal @UMontreal, qui tente d'identifier les variants génétiques à l’origine de la #cardiomyopathiehypertrophique! #communautéFRQ @ESC_Journals @roddywalsh @cbezzina1
https://t.co/vpzwvr3Crt
scientifique-en-chef.gouv.qc.ca
Rafik Tadros, Institut de cardiologie de Montréal
1
5
6
@HeartsInRhythm @PHRIresearch @CIHR_IRSC @SCC_CCS @CHRS_SCR @CANetInc_ @chfalliance @CanadianSADS My first ever Twitter/X post 😵💫😁. We are excited to be launching the TaRGET trial. Additional details here:
3
9
28